[HTML][HTML] Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression
Background Oct4, a key stemness transcription factor, is overexpressed in lung cancer.
Here, we reveal a novel transcription regulation of long non-coding RNAs (lncRNAs) by …
Here, we reveal a novel transcription regulation of long non-coding RNAs (lncRNAs) by …
Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression
IY Kuo, CC Wu, JM Chang, YL Huang… - … journal of cancer, 2014 - Wiley Online Library
The transcriptional network of the SRY (sex determining region Y)‐box 17 (SOX17) and the
prognostic impact of SOX17 protein expression in human cancers remain largely unclear. In …
prognostic impact of SOX17 protein expression in human cancers remain largely unclear. In …
Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription–3 activity independently of the liver kinase B1–AMP-activated …
CC Lin, HH Yeh, WL Huang, JJ Yan… - American journal of …, 2013 - atsjournals.org
Metformin has been used as first-line treatment in patients with type 2 diabetes, and is
reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1) …
reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1) …
Thymic carcinoma: involvement of great vessels indicates poor prognosis
YL Tseng, ST Wang, MH Wu, MY Lin, WW Lai… - The Annals of thoracic …, 2003 - Elsevier
BACKGROUND: Thymic carcinoma is a rare, indolent, and invasive cancer. This study
investigated the treatment results of thymic carcinoma and clinical prognostic factors …
investigated the treatment results of thymic carcinoma and clinical prognostic factors …
[HTML][HTML] Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor …
Background Quality of life (QoL) is important for clinicians to evaluate how cancer survivors
judge their sense of well-being, and WHOQOL-BREF may be a good tool for clinical use …
judge their sense of well-being, and WHOQOL-BREF may be a good tool for clinical use …
Epstein‐barr virus‐associated nonsmall cell lung carcinoma: Undifferentiated" lymphoepithelioma‐like" carcinoma as a distinct entity with better prognosis
FF Chen, JJ Yan, WW Lai, YT Jin… - … International Journal of …, 1998 - Wiley Online Library
Abstract BACKGROUND Epstein‐Barr virus (EBV) infection in nonsmall cell lung carcinoma
(NSCLC) has been demonstrated in some ethnic groups. The pathobiology and the role of …
(NSCLC) has been demonstrated in some ethnic groups. The pathobiology and the role of …
[HTML][HTML] Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established …
WL Huang, HH Yeh, CC Lin, WW Lai, JY Chang… - Molecular cancer, 2010 - Springer
Abstract Background Spontaneous interleukin-6 (IL-6) production has been observed in
various tumors and implicated in the pathogenesis, progression and drug resistance in …
various tumors and implicated in the pathogenesis, progression and drug resistance in …
[HTML][HTML] Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment
The tumor microenvironment plays an important role in tumor growth and metastasis.
However, the mechanism by which tumor cells regulate the cell and non-cell constituents of …
However, the mechanism by which tumor cells regulate the cell and non-cell constituents of …
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer
WP Su, YT Chen, WW Lai, CC Lin, JJ Yan, WC Su - Lung Cancer, 2011 - Elsevier
Many human lung cancer cell lines express apolipoprotein E (ApoE), especially cells
derived from malignant pleural effusions (MPE) in patients with lung adenocarcinoma. This …
derived from malignant pleural effusions (MPE) in patients with lung adenocarcinoma. This …
Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet …
HHW Chen, JJ Yan, WC Chen, MT Kuo, YH Lai… - Lung cancer, 2012 - Elsevier
BACKGROUND: Recent studies have shown that human copper transporter 1 (hCtr1), the
major copper influx transporter, is involved in the transport of platinum-based antitumor …
major copper influx transporter, is involved in the transport of platinum-based antitumor …